DAYANG BIOTECH released its first-quarter performance, with a net profit attributable to the parent company of 29.3432 million yuan, a year-on-year increase of 73.44%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, DAYANG BIOTECH released its Q1 2025 report. In the first quarter, the company achieved operating revenue of 249 million yuan, a year-on-year increase of 27.78%. The net profit attributable to shareholders of the listed company was 29.3432 million yuan, a year-on-year increase of 73.44%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 29.761 million yuan, a year-on-year increase of 88.88%
According to the Zhitong Finance APP, DAYANG BIOTECH (003017.SZ) released its Q1 2025 report. In the first quarter, the company achieved an operating income of 249 million yuan, a year-on-year increase of 27.78%. The net profit attributable to shareholders of the listed company was 29.3432 million yuan, a year-on-year increase of 73.44%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 29.761 million yuan, a year-on-year increase of 88.88%